Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OBA, you mean uplist as in the NYSE or Nasdaq? If so, it wont happen until MJ is legal at the federal level. The only cannabis companies that are on those exchanges are ones that do not sell MJ in the states.
I am looking to but more and would love seeing $2.75. I also agree that this company is a great play in the cannabis space.
https://oracledispatch.com/2019/03/11/is-there-a-pot-of-gold-ahead-for-marimed-inc-otcmktsmrmd/?amp
DewmBoom, thanks!
I expect things to pick up in the late Fall when Canada legalizes cannabis beverages. I dont know if Lexaria is actively working with any beverage company/companies but I assume they are:
https://www.thegrowthop.com/cannabis-news/cannabis-drinks-taste-a-lot-like-urine-but-a-canadian-company-thinks-its-found-a-solution/amp
Lexaria is not mentioned in the article but we all know that DehydraTECH has the ability to mask the taste....and since the technology bypasses liver ingestion it can deliver a quicker "fix" using less product...which would be beneficial to ANY company.
Then when the Altria funded R&D is complete and the technologies ability is proven...hopefully they also receive FDA approval...the flood gates will open to Nicotine and NSAIDs.
It's easy to visualize DehydraTECHs future with Nicotine and Cannabis...but dont overlook the NSAID component. Current NSAIDs destroy the liver.
Liscense, liscense, liscense!
Right! Plus the already existing patent:
“Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof”.
Love the catch all at the end. Lexaria might just have cornered the market because, according to several articles online, it is really challenging to mask the smell or taste of cannabis in beverages. Even though DehydraTECH technology is a delivery system, I am treating this stock as a pharmaceutical stock. Like most pharmaceutical stocks their stock does nothing until clinical trials and/or FDA approval.
IMO the stock is set to explode once human testing is conducted...and successful...AND definitely once Altria incorporates it into their business essentially giving it a global green light.
Does anyone have an idea of how many outstanding shares there are? I swear KGKG is just handing out shares like participation awards. The stock has a 40M market cap. The 65 day avg is 6.3M. Something is fishy! Say the stock was at 0.06 for the last 120 days and traded 6M shares per day...that is $360,000/day...and over their 40M market cap value in 120 days.
Right now, as an 8cent stock trading 6.3M shares/day they are earning their "market cap" every approximately 78 days.
I think drop is due to the head of the FDA stepping down. He was pushing no smoking and no vaping, basically no nicotine in the form of smoke. He gave Lexaria some decent press...but now he is out...so maybe people are questioning their investment and dropping if they were in it for the short term.
Great find!
I dont know, but in 2011 Gateway Industries, went from a penny stock to almost $3/share in one day...an approximate 20,000% gain.
While I agree that a reverse split would help boost the share price...I highly doubt that it will happen unless LXRP wants to list on the NYSE or Nasdaq. Currently they are compliant with the OTCQB requirements. At this point in time they are only required to maintain at least a 1 cent BID.
Hill Street Beverage licensed DehydraTech technology.
Lexaria needs to hire a new PR person. It's like they are trying to be the best kept secret. Here is the article...
https://www.newswire.ca/news-releases/hill-street-drives-brand-interest-and-awareness-with-national-alcohol-free-promotion-813657284.html
Ok, so I listened to the whole thing. The bill ultimately passed unanimously and will be moved to the Committee of Appropriations. There was a representative from MedPharm in attendance. He obviously voiced his opinion in favor of the bill for economic reasons...and expressed that shareholder dollars would allow more money to be used for research and development while at the same time lessen current funding through taxation. There were also some concerns that were brought up. One was in regards to the November 1st implementation statue being too soon. ***The original bill had a July 1st implementation*** The other concern, which seemed to be more important than the implementation date...and voiced by 'Madam Chair'...was she didn't feel like the bill was necessarily worded in a way to favor minorities, and especially female minorities. She ultimately voted yes but made sure she doubled down on her displeasure that it appeared to exclude females and female minorities.
DangIt, I missed it. Anyone have any idea as to the outcome? I cant believe I just listened to almost an hour and a half of some Notory Data Privacy BS...
Supposedly I am listening live...I dont know if I believe that is true. They have 6 hearing items, the one we care about is last, and they are only on the third item. Hopefully they dont run out of time and postpone this item (if that's allowed?).
http://coloradoga.granicus.com/MediaPlayer.php?view_id=19&event_id=7850
You're 100% right. It is upsetting how the stock has managed to fall back to almost pre-Altria share price. I dont know why I keep making excuses when in reality this stock should be much higher. Hopefully you too are in it for the long run...and if so, and you can afford it, keep adding to your position. It's gonna blow up sometime. I just think it may take until October before we see anything significant. I vaguely remember reading somewhere that is when they expect human trials to either start or end. I think right now all their results are based on animal testing (mice).
I am upset with myself. I increased my position in this stock last week when I really should have figured that just before the vote would be a better time to buy...figuring it was the last second of uncertainty.
It's the story of the industry today. Lexy isnt the only one with positive news. Several companies had, what could be perceived as, positive news and they all went down today.
I took it as a 'stocks on sale day' and increase my position.
Obviously CannTrust wants to raise money in order to purchase or acquire something. It's understandable that they are doing it through warrants because it is a challenge, right now, for cannabis companies to get financing from banks. All the update did was tell day traders to sell their shares, at the current high, because a lower share price will present itself in the future allowing them to buy back in. Welcome to the current cannabis investment. It's a day traders wet dream. The stocks are so volatile that they can essentially buy low, sell high and buy back in all in the same day/week/month.
Here is a better link:
https://www.billtrack50.com/BillDetail/1014565
For the sake of the patent conversation, here is the active patent that I am concerned MedPharm's LEAF technology might conflict with:
https://www.lexariabioscience.com/news/lexaria-bioscience-receives-u-s-patent-award-dehydratechtm-delivery-thc-nsaids-nicotine-vitamins/
I am in it for the long haul and excited for the future of both companies.
Thanks. I was also reading the 'Letter to Shareholders' and was concerned with Andy's statement:
"MedPharm currently holds patents on a precise-dose packaging product and an intellectual property for a water-soluble powdered cannabinoid. The packaging allows for accurately dosed cannabis with optimized delivery using MedPharm’s Lipophilic Enhanced Absorption Formula (L.E.A.F.). The powdered cannabinoids also use MedPharm’s L.E.A.F. technology to deliver a product that mixes into water clearly, without any taste, smell or residue, and increases overall bioavailability."
I tried to locate their patent but was unable to find anything on file for MedPharm Holding, LLC except for something in regards to a packaging device.
Knife, this should raise a red flag to you as well since one of the other companies that we hold claims that they have a US patent for “Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof” (patent number 9,839,612 B2...active since 10/2017).
I sent an emailed the company asking for additional clarification and, if possible, the patent number. I will post something if they reply.
I happened to be listening to old YouTube videos about the company and in the New West Summit 2018 Cannabis video Brett Roper (RIP) acknowledged that there were two warrants issues at $1.34 to be exercised March and December 2019 (around the 30min mark of the video). This is all new to me...hopefully someone can explain...but my assumption is that since the stock price is higher than $1.34 we should expect to see it drop over the next month (?) figuring the holders of those warrants will be purchasing shares at a discounted rate and therefore causing the share price to decline?
As always I appreciate your insight!
Dogger, I think there is a misunderstanding. I am a long term player. I believe CannTrust is going to be a major player in their own 'Canada medical cannabis' niche. My previous post was simply saying that i believe that their stock is currently overvalued from where it will be in a month or two from now. I believe the current price per share is slightly inflated due to their recent NYSE uplist and because (American) investors are so inundated with Canadian cannabis companies that they assume every single one is competing for the #1 global powerhouse position. I am hoping/expecting that in the next few days, weeks or months that lower share price dips will appear to buy in. I think long term, because of their money management, this is one of the safer, smarter, cannabis players.
Knife, any thoughts on the chart and whether or not it will present itself with a nice buying opportunity? I know that it has only been a few day but i keep seeing it bounce off the $1.90 like it is the new low resistance...and i am debating adding assuming that once they are able to start their acquisition (if it's signed in the next few days) that we might not see this price again.
So the 0.6's might be coming....but how long until your previously projected 0.4's?
I fully agree with this article. I expect the share price to drop. The company might be cash flow positive however they currently only have the capability to produce 50,000kg of product. They will not be at the century mark until 2020. Even after they hit 100,000kg they still wont be in the top 5 global producers. Either they are hoping for a buyout or they only plan to operate within the Canadian marketplace, and not globally. With that being said, the stock is still riding the high of moving to the NYSE and it is only a matter of time before the stock comes back to reality and the short term flippers move on to some of the other more volatile options.
You want a cheap US play? Check out MDCL. Do your own DD...there are some recent video interviews with their CEO. They are a consulting company but anticipate that by the summer will make two acquisitions (if the govenor signs something expected by the end of Feb) that could turn them into a well rounded cannabis company.
Your right about CannTrust they are different when it comes to financials. That is what I liked about the company and probably why this one could be different once it lists. I honestly dont know what to expect. I only can compare it to what I (think) remember seeing with the other (competitor) companies. HEXO, for instance closed on the OTC 1/22 at $5.31 then opened on the NYSE at $5.60, but by 1/25 hit a daily low of $4.91. This is about were they spent trading all January. The difference with HEXO is that it gradually increased up until it's open on the NYSE. It didnt climb almost $2.50 a week prior to the listing. Once listed, and if it follows suit, I can see it hitting a daily low period around the high 7s, low 8s.
As for VFF, this company is in an entirely different area than primarily cannabis sales and you really cant compare the two.
I was holding out for the February news regarding the governor's signature however there are some really good recent CEO video interviews that make you instantly want to be apart of the company. I also plan to add more when possible.
Fallingknife75, Thanks. I have been researching this company for a while. Saw some hints on another stock board that we happen to share. This reinforced my decision to invest. Sorry for the drop today, somehow the price met my BID. Summer acquisition here we come!
Quiet,
To be honest, I have them on my radar for when they list on the NYSE. The app I use does not allow me to invest in stocks ending in a 5th digit of an "F". I researched them a long time ago (I probably need to revisit) because I wanted to purchase their stock because they are cash flow positive...which is rare with cannabis stocks. Once listed on the NYSE, I will probably still buy a few just to diversify my portfolio and provided the price falls within a range I consider appropriate. With the caveat that I need to revisit my research, I get this feeling that CannTrust is really good at doing what they do, that is provide medical marijuana to Canadian medical patients. Something in my gut tells me that they know this and they plan on only thriving in this niche...for the long term...and I could be 100% wrong here...but I feel that they might be up listing to take advantage of American shareholder dollars, while really have no intentions to compete with the larger, soon to be, global cannabis companies that one might have assumed. Anyway, all my research has pointed me at the same conclusion. The Canadian companies know that in order to be truly profitable in the long term they need the American (consumer) market. Conveniently, most of the U.S. companies are a fraction of the cost per share. I am sure that there are plenty out there that are worthy of inventing in...you just have to do you DD and hope that your research doesn't fail you...while at the same time know that any investment comes with risk.
Pied, I dont have private messaging but this board is inactive. Check out MDCL. By the end of the summer they should be the MRMD of the Mideast.
Rock_nj, Share price means everything to individuals who are investing money from their change purse. The less the stock price the more shares they can buy. Aside from Dentman1 saying that he was new to the game I was under the impression that he had a set amount of funds and hoping to get as many shares as possible. Yes, I agree that more people invest in NYSE listed companies over the OTC because the companies that uplist go through a tougher vetting process. I also noticed that investors tend to jump in before the uplist and inflate the stock. Once listed the stock will spike up and down for a few days or so before settling in. It's not that I dont think CannTrust will do well once on the NYSE. I just wanted to let him know that he has options and shouldn't feel the need to race into buying before the event. That if he plays it right he might be able to afford more shares during a down spike once it lists.
Here is an question. Do you think an APHA acquisition will happen before May 6th? I honestly dont think it will. We all received our Green Growth take over bid document as well as the APHA follow up. In the packet our shareholder decision was due by May 6th (at least this is the date I think I remember reading). I know APHA rejected the bid but are they required by law (like to allow shareholder voice...or something) to at least wait until the full term of the proposal before accepting any other bids?
Personally I think the share price is a little high. If it is like the other cannabis stocks...they went up before their NYSE listing, spiked when they listed and then fell back to reality. I am not telling you what to do...the app I use doesnt allow me to purchase stocks ending in "F"...but I know I plan on picking up shares after the initial excitement from their NYSE uplist wears off.
Noobie, I keep hanging on because of a few things. (1) Cannabis, as an investment, is in its infancy stages, especially in the US. (2) Cannabis companies want in the US because when marijuana becomes legal at the Federal level they know that is where most of their profits will be made and Marimed seems to be positioning itself well by being in multiple states. (3) The fact that they own GenCanna. If it truly is the largest hemp producer in the US then there is a chance that someone will want to acquire it. Until then...according to posts on this forum...this stock will be a constant rollercoaster.
Any idea of the other companies/stocks run by Robert Fireman? I believe they are WDDD and WORX. Do they tie into MRMD? It sounds like they are completely separate but the healthcare software piece may be provide healthcare practitioners with medical marijuana research. I wonder if, since these are all OTC stocks, if the volatility of MRMD...like spiking at $5 then falling immediately back to $3.50...is because they are robbing Peter to pay Paul?
Bloodguard, that doesnt make any sense. A tracking number (not shipping number) could/would be site specific however an invoice number is an internal, sequential, reference number assigned to any order at the purchasing system level which are typically used for accounting purposes.